BARD1 Life Sciences Ltd BDLSF:OTCPK

RT Quote | Exchange | USD
Last | EDT
UNCH (UNCH)
52 week range
0.00 - 0.00

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap211.1M
  • Shares Out79.82M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap211.1M
  • Shares Out79.82M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From BARD1 Life Sciences Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
BARD1 Life Sciences Limited is an Australia-based medical diagnostics company. The Company is focused on the development and commercialization of diagnostic solutions for health care professionals and patients. The Company’s technologies include BARD1, hTERT, SIEN-NET and SubB2M. The hTERT is an immunocytochemistry (ICC) assay that detects human telomerase reverse transcriptase (hTERT). The BARD1 is a biomarker platform covering various tumor markers including nucleic acids...
Leearne Hinch
Chief Executive Officer
Address
Harry Perkins Institute
Off Medical Research 6 Verdun Street
Nedlands, WAS
6009
Australia